Development and Practical Test of Quality Indicators for Palliative Care in Patients With Chronic Heart Failure
Yasuhiro Hamatani(National Cerebral and Cardiovascular Center), Toshihisa Anzai(Hokkaido University), Satoshi Yasuda(Tohoku University), Yasuko Takada(National Cerebral and Cardiovascular Center), Mitsunori Nishikawa(National Center for Geriatrics and Gerontology), Hisao Ogawa(Kumamoto University Hospital), Yoshihiro Fukumoto(Kurume University), Yoshihiro Miyamoto(Asahikawa City Hospital), Yuta Anchi(National Cerebral and Cardiovascular Center), Hiroto Ito(National Center of Neurology and Psychiatry), Tsuyoshi Shiga(Tokyo Women's Medical University), Chisato Izumi(National Cerebral and Cardiovascular Center), Atsushi Suzuki(Tokyo Women's Medical University), Masashi Kato(National Cancer Center), Yasuo Sugano(keiyu Hospital), Yukie Kawano(National Cerebral and Cardiovascular Center), Tatsuhiro Shibata(United Cerebral Palsy)
Cited by 25
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
|Journal of Atherosclerosis and Thrombosis|2018|821